Pharmaceutical Executive
Weighing the benefits of a deeper quantitative review for pharma.
Greg Belogolovsky
Advertisement
Articles by Greg Belogolovsky
Pharmaceutical Executive
How drug developers can include strategy in R&D portfolio review to decide how to allocate resources across current and future projects.
Advertisement
Latest Updated Articles
A Strategic Approach to Pharma R&D Portfolio PlanningApril 23rd 2019
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
2
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
3
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
4
What Are the ‘Last Mile Issues’ Impacting Pharma?
5